Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Mayo Clinic Utilizes Autologous Stem Cells to Treat Heart Failure Patients in First Clinical Study to Target the Regeneration of a Failing Organ

Posted by [email protected] on Jun 7, 2013 2:58:53 PM

Researchers at Mayo Clinic have introduced a new therapy using cardiogenically-instructed stem cells that can improve heart health. This is the first clinical study for the targeted regeneration of a failing organ. The Mayo Clinic study represents what we believe to be the gold standard in regenerative treatments – utilizing the patient’s own stem cells for the therapy. As a result of the use of autologous [the patient’s own] stem cells, there were no complications in any of the patients. Every patient in the stem cell treatment group improved. "The benefit to patients who received cardiopoietic stem cell therapy was significant," said Dr. Terzic – the senior author of the study, with improvements in heart pumping function, physical performance (such as walking distance) and overall quality of life.

Read More

Topics: Dr. Terzic, Heart, stemsaveblog, Heart Failure, clinical trials, Stemcells, clinical trial, Heart Attack, Mayo Clinic, autologousstemcells, Ischemic Cardiomyopathy, heart disease

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Recent Posts

Posts by Topic

see all